ClinLabNavigator Logo
Analyzing Samples
Available Test Interpretations
Date Rape Drugs
DDimer for DIC
DDimer for DVT
Dehydroepiandrosterone
Dehydroepiandrosterone Sulfate
Deoxycorticosteroids
Deoxyribonuclease B Ab
Dexamethasone Suppression Cushing Syndrome
Dexamethasone Suppression Depression
Dexamethasone Suppression Test
Diabetes Mellitus
Diabetes Mellitus Management
Differential Leukocyte Count
Digoxin
Dilute Russel Viper Venom Time
Direct Antiglobulin Test
Disseminated Intravascular Coagulation
DNA Antibody
Donath Landsteiner Antibody
Drug Induced Thrombocytopenia
Drug of Abuse Screen
Drugs of Abuse Workplace Testing
Test Interpretations
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Deoxycorticosteroids

Print This Page
E-mail This Page

11-Deoxycortisol is the predominant deoxycorticosteroid and is the immediate precursor of cortisol. 11-Deoxycortisol is typically increased when ACTH is elevated, such as occurs in Cushing's disease and ACTH producing tumors. It is also increased in adrenogenital syndrome.



11-Deoxycortisol is measured as part of the Metyrapone Test. Metyrapone blocks the formation of cortisol, resulting in increased secretion of ACTH and 11-deoxycortisol in normal individuals. Patients with pituitary or adrenal failure do not increase ACTH secretion or deoxycorticosteroid production after metapyrone administration. An impaired 11-deoxycortisol response confirms the diagnosis of adrenal insufficiency, but does not differentiate primary and secondary causes of adrenal failure.

The test should not be done if plasma cortisol levels are < 3 ug/dL. Estrogen and phenytoin may cause an impaired response to metyrapone.

The reference range is:

  08:00 Specimen

16:00 Specimen

0 - 5 ug/dL

0 - 3 ug/dL



Specimen requirement is one green top (heparin) tube of blood.